Johnson & Johnson (JNJ) Operating Margin (2009 - 2026)
Johnson & Johnson (JNJ) posted Operating Margin of 26.44% for Q1 2026, down 67.62% sequentially from 81.68% in Q4 2025, and down 179.0% YoY from 33.47% in Q1 2025.
Johnson & Johnson (JNJ) Operating Margin (2009 - 2026) Analysis & Trends
Johnson & Johnson (JNJ) has 18 years of Operating Margin data on file, last reported at 26.44% in Q1 2026.
- Quarterly Operating Margin fell 179.0% year-over-year to 26.44% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 41.62% (up 1779.0% YoY) and the FY2025 annual result came in at 42.39%, up 1873.0% from the prior year.
- Operating Margin fell to 26.44% in Q1 2026 per JNJ's latest filing, from 81.68% in the prior quarter.
- The five-year high for Operating Margin was 88.12% in Q4 2023, with the low at 15.98% in Q4 2024.
- Average Operating Margin over 5 years is 33.75%, with a median of 27.36% recorded in 2023.
- Year-over-year, Operating Margin plunged 7214 bps in 2024 and jumped 6570 bps in 2025.
- Johnson & Johnson's Operating Margin stood at 26.5% in 2022, then soared by 233 bps to 88.12% in 2023, then plunged by 82 bps to 15.98% in 2024, then surged by 411 bps to 81.68% in 2025, then sank by 68 bps to 26.44% in 2026.
- Business Quant data shows JNJ's Operating Margin at 26.44% in Q1 2026, 81.68% in Q4 2025, and 29.31% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 47.98% |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 26.44% |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 26.60% |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | 29.51% |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | -47.46% |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 30.94% |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 37.16% |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | -286.83% |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Biogen | 30.87 Bn | 26.59 Bn | 1.82 Bn | -11.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | 26.44% |
| Dec 28, 2025 | 81.68% |
| Sep 28, 2025 | 29.31% |
| Jun 29, 2025 | 27.99% |
| Mar 30, 2025 | 28.24% |
| Dec 29, 2024 | 15.98% |
| Sep 29, 2024 | 22.42% |
| Jun 30, 2024 | 28.82% |
| Mar 31, 2024 | 27.63% |
| Dec 31, 2023 | 88.12% |
| Oct 1, 2023 | 26.88% |
| Jul 2, 2023 | 27.01% |
| Apr 2, 2023 | 27.36% |
| Jan 1, 2023 | 48.19% |
| Oct 2, 2022 | 26.50% |
| Jul 3, 2022 | 19.19% |
| Apr 3, 2022 | 21.94% |
| Oct 3, 2021 | 28.31% |
| Jul 4, 2021 | 26.60% |
| Apr 4, 2021 | 29.55% |